Biofrontera BFRI
NASDAQ BFRI
$0.94 +0.01 (+1.02%)
At close: Nov 11, 2026 · 4:00 PM EST

Biofrontera (BFRI) Asset Writedowns and Impairment (2021)

Updated

Biofrontera (BFRI) recorded Asset Writedowns and Impairment of $100,000 in FY2022, up 203.0% from $33,000 in FY2021.

Analysis

Biofrontera (BFRI) Asset Writedowns and Impairment (2021) Analysis & Trends

  • Per Business Quant data, BFRI's Asset Writedowns and Impairment was $33,000 in FY2021 (-91.8%) and $401,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Biofrontera 13.21 Mn -7.66 Mn 9.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 2,000.00
Sep 30, 2021 -3,000.00
Jun 30, 2021 -1,000.00
Mar 31, 2021 35,000.00
API Access

Biofrontera Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=BFRI&period=max&api_key=YOUR_API_KEY